Akso Health (AHG) Non-Current Deffered Revenue (2019 - 2020)
Akso Health's (AHG) quarterly Non-Current Deffered Revenue came in at $96228.0 in Q1 2020, down 49.34% YoY from $189958.0 in Q2 2019, and down 38.04% on a QoQ basis from $155300.0 in Q3 2019.
Akso Health (AHG) Non-Current Deffered Revenue (2019 - 2020) Analysis & Trends
Akso Health (AHG) has 2 years of Non-Current Deffered Revenue data on file, last reported at $96228.0 in Q1 2020.
- Quarterly Non-Current Deffered Revenue fell 49.34% year-over-year to $96228.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $96228.0 (down 49.34% YoY) and the FY2020 annual result came in at $96228.0, down 49.34% from the prior year.
- Non-Current Deffered Revenue retreated to $96228.0 in Q1 2020, from $155300.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $189958.0 in Q1 2019 to a low of $96228.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | - |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | - |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 923,000.00 |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | - |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | - |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | - |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 96,228.00 |
| Sep 30, 2019 | 155,300.00 |
| Mar 31, 2019 | 189,958.00 |